Review
Published on 23 Nov 2023
Overcoming the myths of esketamine administration: different and not difficult
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1279657
- 5,377 views
- 4 citations
Type at least 3 characters
531 articles
Articles
Perspective
Published on 21 Nov 2023
Biological studies of clavine alkaloids targeting CNS receptors
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1286941
- 2,082 views
- 3 citations
Editorial
Published on 17 Nov 2023
Editorial: The pros and cons of psychotropic drug-induced changes in periphery and central nervous system: elucidating structural and molecular mechanisms
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1269307
- 1,056 views
Original Research
Published on 13 Nov 2023
Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1287196
- 3,129 views
- 4 citations
Editorial
Published on 06 Nov 2023
Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1306117
- 2,326 views
Original Research
Published on 03 Nov 2023
The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1271165
- 1,529 views
Original Research
Published on 02 Nov 2023
Home-administered transcranial direct current stimulation with asynchronous remote supervision in the treatment of depression: feasibility, tolerability, and clinical effectiveness
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1206805
- 3,459 views
- 1 citation
Case Report
Published on 25 Oct 2023
Case report: Maintaining altered states of consciousness over repeated ketamine infusions may be key to facilitate long-lasting antidepressant effects: some initial lessons from a personalized-dosing single-case study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1197697
- 2,379 views
Editorial
Published on 19 Oct 2023
Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1305478
- 2,327 views
Case Report
Published on 10 Oct 2023
Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1257984
- 2,975 views
- 2 citations
Original Research
Published on 06 Oct 2023
Paliperidone long-acting injection in the treatment of an adolescent with schizophrenia with fluctuating mental symptoms during menstrual period: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1276983
- 2,549 views
- 1 citation
Original Research
Published on 03 Oct 2023
Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1257755
- 2,440 views
- 2 citations
Systematic Review
Published on 22 Sep 2023
Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1248397
- 10,171 views
- 1 citation
Perspective
Published on 20 Sep 2023
Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1159843
- 3,064 views
Original Research
Published on 19 Sep 2023
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1199642
- 41,625 views
- 19 citations
Methods
Published on 19 Sep 2023
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1268832
- 11,638 views
- 4 citations